- US12612381utility2026Crystalline Forms of N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide0 cites
- US12428376utility2025Therapeutic Compounds and Compositions0 cites
- US12377093utility2025Pyruvate Kinase Activators for Use in Therapy0 cites
- US12133853utility2024Pyruvate Kinase Activators for Use in Treating Blood Disorders0 cites
- US11957680utility2024Pyruvate Kinase Activators for Use in Treating Blood Disorders0 cites
- US11919915utility2024Compounds and Methods Useful for Stabilizing Phenylalanine Hydroxylase Mutations0 cites
- US11878049utility2024Mitapivat Therapy and Modulators of Cytochrome P4500 cites
- US11872225utility2024Pyruvate Kinase Modulators and Use Thereof0 cites
- US11793806utility2023Pyruvate Kinase Activators for Use in Therapy0 cites
- USRE049582reissue2023Therapeutic Compounds and Compositions0 cites
- US11590132utility2023Pyruvate Kinase Activators for Use in Treating Blood Disorders0 cites